approved EB-1A
Senior Scientist
Cancer Immunotherapy · India · 2022-03-24
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 9 peer-reviewed scientific articles in the field of cancer immunotherapy.
Judging (Met)
The petitioner was invited to review and evaluate the work of her peers on at least 2 occasions.
Original Contributions (Met)
The petitioner made original contributions through the development of CAR T cell-based immunotherapies, evidenced by 554 citations and patent activity.
Why This Petition Was Approved
The petition was approved based on the petitioner's significant contributions to cancer immunotherapy, including 9 peer-reviewed scientific articles and 554 citations. She demonstrated her authority through 2 peer-review judging invitations and the filing of 1 patent and 2 patent applications. The case satisfied EB-1A criteria by showing her work is widely recognized and relied upon by researchers in at least 49 countries.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
- 9 peer-reviewed scientific articles
- 554 citations according to Google Scholar
- 1 patent and 2 patent applications
- 2 peer-review judging invitations
- 4 expert recommendation letters
- Citations from researchers in at least 49 countries
Similar Cases
Research Scientist
Biotechnology · India
WeGreened EB-1A approved
New Jersey 8 days 2022-02-02
The petition was approved based on 6 peer-reviewed scientific articles and a high citation count of 1,088, demonstrating international appeal. Additionally, the petitioner's role in conducting 19 peer reviews for respected journals satisfied the judging criterion for EB-1A. Her work on unique anti-cancer drugs addressed pressing national health needs.
Principal
Biotechnology · India
WeGreened EB-1A approved
California 123 days 2025-07-23
The case was approved based on 5 peer-reviewed journal articles in high-impact venues like Nature, Cell, and Science, which amassed 1,359 citations from researchers in over 50 countries. The petitioner also demonstrated significant judging experience with 13 peer reviews and an editorial board position. These metrics satisfied the criteria for original contributions of major significance, scholarly authorship, and judging the work of others.
Postdoctoral Researcher
Biotechnology · Iran
WeGreened EB-1A approved
Texas 15 days 2025-05-13
The petition was approved based on 7 peer-reviewed journal articles and 377 citations from researchers in 56 countries. The applicant demonstrated her expert status through 40 completed peer reviews for scientific journals. Additionally, her ranking in the top 1% of highly cited researchers in vaccine therapy and international funding support from the Biotechnology Development Council of Iran satisfied the EB-1A criteria.
Doctor
Healthcare · Taiwan
WeGreened EB-1A approved
Connecticut 14 days 2025-07-21
The petition was approved based on a substantial publication record of 33 peer-reviewed journal articles and 36 abstracts. The petitioner demonstrated global impact with 209 citations from researchers in 19 countries. Additionally, the case satisfied the judging criterion through 15 journal peer reviews and service on editorial boards.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-24.
Browse all casesAt a Glance
Outcome approved
Processing 3 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist